Bone Biologics Corp — Director's Dealing 2023

Sep 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2023-09-18

Reporting Person: Lucera Erick (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-18	Non-Employee Stock Option	$0.64	A	85763	Acquired	2033-09-13	Common Stock (85763)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Employee Stock Option	$48.41	2027-08-23	Common Stock (1229)	1229	Direct
Non-Employee Stock Option	$105.60	2032-01-01	Common Stock (291)	291	Direct
Non-Employee Stock Option	$157.50	2031-10-26	Common Stock (99)	99	Direct
Non-Employee Stock Option	$157.50	2031-10-15	Common Stock (667)	677	Direct

Footnotes

F1: Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant.

F2: This option is fully vested as of the date of this report.